Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stock-based Compensation

v3.10.0.1
Note 6 - Stock-based Compensation
3 Months Ended
Jul. 01, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
N
ote
6
– S
tock-based Compensation
 
The Company has
two
incentive stock plans, the
2006
Omnibus Incentive Plan (the
“2006
Plan”) and the
2014
Omnibus Equity Compensation Plan (the
“2014
Plan”). As a result of the approval of the
2014
Plan by the Company’s stockholders at the Company’s
2014
annual meeting, grants
may
no
longer be issued under the
2006
Plan.
 
The Company believes that awards of long-term, equity-based incentive compensation will attract and retain directors, officers and employees of the Company and will encourage these individuals to contribute to the successful performance of the Company, which will lead to the achievement of the Company’s overall goal of increasing stockholder value. Awards granted under the
2014
Plan
may
be in the form of incentive stock options, non-qualified stock options, shares of restricted or unrestricted stock, stock units, stock appreciation rights or other stock-based awards. Awards
may
be granted subject to the achievement of performance goals or other conditions, and certain awards
may
be payable in stock or cash, or a combination of the two. The
2014
Plan is administered by the Compensation Committee of the Company’s Board of Directors (the “Board”), which selects eligible employees, non-employee directors and other individuals to participate in the
2014
Plan and determines the type, amount, duration (
not
to exceed
ten
(
10
) years for grants of options) and other terms of individual awards. Grants under the
2014
Plan are settled primarily through the issuance of new shares of the Company’s common stock,
562,000
shares of which were available for future issuance under the
2014
Plan as of
July 1, 2018.
 
Stock-based compensation expense is calculated according to FASB ASC Topic
718,
Compensation – Stock Compensation
, which requires stock-based compensation expense to be accounted for using a fair-value-based measurement. The Company recorded stock-based compensation expense of
$110,000
and
$142,000
for the
three
months ended
July 1, 2018
and
July 2, 2017,
respectively. The Company records the compensation expense related to stock-based awards granted to individuals in the same classifications in the accompanying unaudited condensed consolidated statements of income as the cash compensation paid to those same individuals.
No
stock-based compensation costs have been capitalized as part of the cost of an asset as of
July 1, 2018.
 
Stock Options:
The following table represents stock option activity for the
three
-month periods ended
July 1, 2018
and
July 2, 2017:
 
   
Three-Month Period Ended
   
Three-Month Period Ended
 
   
July 1, 2018
   
July 2, 2017
 
   
Weighted-
   
 
 
 
 
Weighted-
   
 
 
 
   
Average
   
Number of
   
Average
   
Number of
 
   
Exercise
   
Options
   
Exercise
   
Options
 
   
Price
   
Outstanding
   
Price
   
Outstanding
 
Outstanding at Beginning of Period
  $
7.93
     
395,000
    $
8.35
     
322,500
 
Granted
   
5.90
     
110,000
     
7.75
     
110,000
 
Forfeited
   
-
     
-
     
9.19
     
(15,000
)
Outstanding at End of Period
   
7.48
     
505,000
     
8.17
     
417,500
 
Exercisable at End of Period
   
8.15
     
315,000
     
8.03
     
252,500
 
 
As of
July 1, 2018,
the intrinsic value of the outstanding and exercisable stock options was
$13,000
and
$10,000,
respectively. There were
no
options exercised during either of the
three
-month periods ended
July 1, 2018
or
July 2, 2017.
 
To determine the estimated fair value of stock options granted, the Company uses the Black-Scholes-Merton valuation formula, which is a closed-form model that uses an equation to estimate fair value. The following table sets forth the assumptions used to determine the fair value of the non-qualified stock options that were awarded to certain employees during the
three
-month periods ended
July 1, 2018
and
July 2, 2017,
which options vest over a
two
-year period, assuming continued service.
 
   
Three-Month Periods Ended
 
   
July 1, 2018
   
July 2, 2017
 
Number of options issued
   
110,000
     
110,000
 
Grant date
 
June 13, 2018
   
June 8, 2017
 
Dividend yield
   
5.42
%    
4.13
%
Expected volatility
   
25.00
%    
25.00
%
Risk free interest rate
   
2.78
%    
1.47
%
Contractual term (years)
   
10.00
     
10.00
 
Expected term (years)
   
4.00
     
3.00
 
Forfeiture rate
   
5.00
%    
5.00
%
Exercise price (grant-date closing price) per option
  $
5.90
    $
7.75
 
Fair value per option
  $
0.49
    $
0.85
 
 
For the
three
-month periods ended
July 1, 2018
and
July 2, 2017,
the Company recorded compensation expense associated with stock options as follows (in thousands):
 
   
Three-Month Period Ended July 1, 2018
   
Three-Month Period Ended July 2, 2017
 
   
Cost of
   
Marketing &
   
 
 
 
 
Cost of
   
Marketing &
   
 
 
 
   
Products
   
Administrative
   
Total
   
Products
   
Administrative
   
Total
 
Options Granted in Fiscal Year
 
Sold
   
Expenses
   
Expense
   
Sold
   
Expenses
   
Expense
 
2016
  $
-
    $
-
    $
-
    $
6
    $
1
    $
7
 
2017
   
6
     
5
     
11
     
10
     
2
     
12
 
2018
   
7
     
8
     
15
     
2
     
1
     
3
 
2019
   
-
     
1
     
1
     
-
     
-
     
-
 
                                                 
Total stock option compensation
  $
13
    $
14
    $
27
    $
18
    $
4
    $
22
 
 
 
As of
July 1, 2018,
total unrecognized stock option compensation expense amounted to
$103,000,
which will be recognized as the underlying stock options vest over a weighted-average period of
1.2
years. The amount of future stock option compensation expense could be affected by any future stock option grants and by the separation from the Company of any individual who has received stock options that are unvested as of such individual’s separation date.
 
Non-vested Stock
Granted to
None
mployee Directors:
The Board granted the following shares of non-vested stock to the Company’s nonemployee directors:
 
Number of Shares
   
Fair Value per Share
 
Grant Date
28,000      
$5.50
 
August 9, 2017
28,000      
10.08
 
August 10, 2016
28,000      
8.20
 
August 12, 2015
 
These shares vest over a
two
-year period, assuming continued service. The fair value of the non-vested stock granted to the Company’s nonemployee directors was based on the closing price of the Company’s common stock on the date of each grant.
 
Performance Bonus Plan:
  The Company maintains a performance bonus plan for certain executive officers that provides for awards of shares of common stock in the event that the aggregate average market value of the common stock during the relevant fiscal year, plus the amount of cash dividends paid in respect of the common stock during such period, increases. These individuals
may
instead be awarded cash, if and to the extent that insufficient shares of common stock are available for issuance from all shareholder-approved, equity-based plans or programs of the Company in effect. The performance bonus plan also imposes individual limits on awards and provides that shares of common stock that
may
be awarded will vest over a
two
-year period. Compensation expense associated with performance bonus plan awards are recognized over a
three
-year period – the fiscal year in which the award is earned, plus the
two
-year vesting period.
 
In connection with the performance bonus plan, the Company granted shares of common stock and recognized or will recognize compensation expense as set forth below:
 
   
 
 
 
 
 
 
 
 
Fair
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fiscal
 
 
 
 
 
Fiscal
   
Value
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year
 
Shares
   
Year
   
Per
   
Compensation expense recognized during fiscal year
 
Earned
 
Granted
   
Granted
   
Share
   
2016
   
201
7
   
201
8
   
201
9
 
2016
   
41,205
     
2017
    $
7.865
    $
108,000
    $
108,000
    $
108,000
    $
-
 
2017
   
42,250
     
2018
     
8.271
     
-
     
116,000
     
116,000
     
116,000
 
 
The table below sets forth the vesting of shares issued in connection with the grants of shares set forth in the above table. Each of the individuals holding shares that vested surrendered to the Company the number of shares necessary to satisfy the income tax withholding obligations that arose from the vesting of the shares. The table below also sets forth the taxes remitted to the appropriate taxing authorities on behalf of such individuals.
 
   
 
 
 
 
Vesting of shares during the three-month periods ended
 
Fiscal
 
 
 
 
 
July
1
, 201
8
   
July
2
, 201
7
 
Year
 
Shares
   
Shares
   
Aggregate
   
Taxes
   
Shares
   
Aggregate
   
Taxes
 
Granted
 
Granted
   
Vested
   
Value
   
Remitted
   
Vested
   
Value
   
Remitted
 
2017
   
41,205
     
20,601
    $
122,000
    $
39,000
     
20,604
    $
167,000
    $
56,000
 
2018
   
42,250
     
21,125
     
124,000
     
56,000
     
-
     
-
     
-
 
                                                         
   
Total
     
41,726
    $
246,000
    $
95,000
     
20,604
    $
167,000
    $
56,000
 
 
For the
three
-month periods ended
July 1, 2018
and
July 2, 2017,
the Company recorded compensation expense associated with stock grants, which is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income, as follows (in thousands):
 
   
Three-Month Period Ended July 1, 2018
   
Three-Month Period Ended July 2, 2017
 
   
 
 
 
 
Nonemployee
   
Total
   
 
 
 
 
Nonemployee
   
Total
 
Stock Granted in Fiscal Year
 
Employees
   
Directors
   
Expense
   
Employees
   
Directors
   
Expense
 
2016
  $
-
    $
-
    $
-
    $
-
    $
29
    $
29
 
2017
   
-
     
35
     
35
     
27
     
35
     
62
 
2018
   
29
     
19
     
48
     
29
     
-
     
29
 
                                                 
Total stock grant compensation
  $
29
    $
54
    $
83
    $
56
    $
64
    $
120
 
 
As of
July 1, 2018,
total unrecognized compensation expense related to the Company’s non-vested stock grants amounted to
$183,000,
which will be recognized over the respective vesting terms associated with each block of non-vested stock indicated above, such grants having an aggregate weighted-average vesting term of
151
days. The amount of future compensation expense related to the Company’s non-vested stock grants could be affected by any future non-vested stock grants and by the separation from the Company of any individual who has non-vested stock grants as of such individual’s separation date.